| Product NDC: | 0143-1300 |
| Proprietary Name: | Lithium Carbonate |
| Non Proprietary Name: | Lithium Carbonate |
| Active Ingredient(s): | 300 mg/1 & nbsp; Lithium Carbonate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0143-1300 |
| Labeler Name: | West-ward Pharmaceutical Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078715 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101228 |
| Package NDC: | 0143-1300-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0143-1300-01) |
| NDC Code | 0143-1300-01 |
| Proprietary Name | Lithium Carbonate |
| Package Description | 100 TABLET in 1 BOTTLE (0143-1300-01) |
| Product NDC | 0143-1300 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lithium Carbonate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101228 |
| Marketing Category Name | ANDA |
| Labeler Name | West-ward Pharmaceutical Corp |
| Substance Name | LITHIUM CARBONATE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Mood Stabilizer [EPC] |